Table 2 Summary of patients' clinical characteristics
Characteristics | BELs (n = 106) | EC (n = 126) | p value |
|---|---|---|---|
Age at diagnosis, years†|  |  | < 0.001* |
 ≤ 50 | 65 (61.3) | 42 (33.3) |  |
 51–64 | 34 (32.1) | 77 (61.1) |  |
 ≥ 65 | 7 (6.6) | 7 (5.6) |  |
BMI, kg/m2†|  |  | 0.405 |
 ≤ 24.9 | 48 (45.3) | 49 (38.9) |  |
 25–29.9 | 42 (39.6) | 50 (39.7) |  |
 ≥ 30 | 16 (15.1) | 27 (21.4) |  |
Menopausal status†|  |  | 0.065 |
 Premenopausal | 60 (56.6) | 56 (44.4) |  |
 Postmenopausal | 46 (43.4) | 70 (55.6) |  |
Nulliparity†|  |  | 0.092 |
 No | 103 (97.2) | 116 (92.1) |  |
 Yes | 3 (2.8) | 10 (7.9) |  |
Diabetes†|  |  | 0.698 |
 No | 99 (93.4) | 116 (92.1) |  |
 Yes | 7 (6.6) | 10 (7.9) |  |
PCOS†|  |  | 0.358 |
 No | 106 (100) | 125 (99.2) |  |
 Yes | 0 (0) | 1 (0.8) |  |
Long-term tamoxifen therapy†|  |  | 0.001* |
 No | 91 (85.8) | 123 (97.6) |  |
 Yes | 15 (14.2) | 3 (2.4) |  |
CA125(+)†| 11 (10.4) | 14 (11.1) | 0.858 |
CA199(+)†| 3 (2.8) | 11 (8.7) | 0.06 |